Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,697,056
+$3,167,797 QoQ
Shares Held
280,838
+0.3% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#145
of 3,140 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026&PARTNERS holds $840,453,680 across 15 Drug Manufacturers - General names. AMGN ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
180,745 | $216,790,993 | |
| 2 | JNJ |
Johnson & Johnson
|
809,873 | $205,683,445 | |
| 3 | ABBV |
AbbVie Inc.
|
425,683 | $107,118,870 | |
| 4 | AMGN |
Amgen Inc
This page
|
280,838 | $101,697,056 | |
| 5 | MRK |
Merck & Co., Inc.
|
562,388 | $72,266,858 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
403,145 | $50,933,339 | |
| 7 | NVS |
Novartis AG
|
147,424 | $23,104,289 | |
| 8 | AZN |
Astrazeneca PLC
|
99,983 | $18,958,776 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,697,056 | 280,838 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $98,529,259 | 280,032 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $91,505,729 | 279,569 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $69,148,030 | 245,032 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $67,849,426 | 243,005 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $64,038,479 | 205,548 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $47,098,429 | 180,703 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,647,368 | 88,909 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,772,643 | 40,879 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,574,517 | 9,055 | Shares | Sole | 2024-04-11 | |
| 2023-09-30 | $1,740,758 | 6,477 | Shares | Sole | 2023-10-06 | |
| 2023-06-30 | $1,436,025 | 6,468 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $1,563,639 | 6,468 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $1,690,351 | 6,436 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $1,509,729 | 6,698 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,630,110 | 6,700 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $1,619,710 | 6,698 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,504,824 | 6,689 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,422,415 | 6,689 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,630,443 | 6,689 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $1,639,409 | 6,589 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $1,514,942 | 6,589 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $1,649,244 | 6,489 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $1,530,495 | 6,489 | Shares | Sole | 2020-07-07 | |
| No filing history on record for this holder in this stock. | ||||||